Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Maria De Santis, Sara Martínez Breijo, Paul Robinson,Camille Capone,Katie Pascoe,Suzy Van Sanden,Mahmoud Hashim, Marco Trevisan,Caitlin Daly, Friso Reitsma,Sophie van Beekhuizen, Haoyao Ruan,Bart Heeg,Elena Verzoni

Advances in Therapy（2024）

引用 0|浏览11

关键词

BRCA,Indirect treatment comparisons,Metastatic castration-resistant prostate cancer,Network meta-analysis,Niraparib plus abiraterone acetate dual-action tablet,PARPi,Population-adjusted indirect comparisons

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要